MDB capital co-founder Marlett buys $2565 in shares

Published 20/06/2025, 16:24
MDB capital co-founder Marlett buys $2565 in shares

Christopher Marlett, Co-Founder of MDB Capital Holdings, LLC (NASDAQ:MDBH), reported purchasing 635 shares of common stock on June 18, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The $40.4M market cap company trades at an attractive P/E ratio of 4.5x, though InvestingPro analysis suggests the stock is currently fairly valued.

The shares were bought at prices ranging from $4.00 to $4.06, with an average weighted price of $4.04, totaling $2565. Following the transaction, Marlett directly owns 142,670 shares. This insider purchase comes as the stock has declined nearly 36% over the past six months. InvestingPro subscribers have access to 8 additional key insights about MDBH, including detailed analysis of its financial health and growth prospects.

In other recent news, MDB Capital Holdings LLC announced its second-quarter 2025 earnings, revealing a decrease in net current assets by approximately $2.3 million and cash utilization under $2 million. The firm remains committed to achieving cash flow neutrality, focusing on strategic financing and revenue from its PatentVest platform. MDB Capital also closed a significant deal with HeartBeam, marking its sole financing activity for the quarter. Additionally, the company plans to introduce 3-4 new investment opportunities annually, targeting companies nearing revenue and profitability. In a strategic move, MDB Capital reshuffled its Board of Directors, appointing Dan Torpey as the new Chair of the Audit Committee. Torpey brings over two decades of experience from Ernst & Young LLP, which is expected to enhance the company’s governance and operational standards. CEO Chris Marlett expressed confidence in the firm’s strategic focus and the current market environment, despite challenges in the venture capital market. These developments underscore MDB Capital’s ongoing efforts to sustain growth and leverage its unique position in public venture capital.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.